It was reported during flow rate testing of a spectrum pump, it was observed that there was an underinfusion while using a clearlink system continu-flo solution set.During testing via a spectrum pump, the infusion was ¿within +/- 5% of the intended flow rate.¿ the testing was performed in a laboratory setting with no patient involvement.No additional information is available.
|
H10: the device was received for evaluation.Visual inspection did not identify any abnormalities that could have contributed to the reported condition.A functional testing including, dimensional, pressure, stability and clear passage under water testing was all performed, and the device was found to be within the product specification range.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|